Bioorganic and Medicinal Chemistry Letters p. 2677 - 2682 (1996)
Update date:2022-08-02
Topics:
Friesen, Richard W.
Dube, Daniel
Fortin, Rejean
Frenette, Richard
Prescott, Sylvie
Cromlish, Wanda
Greig, Gillian M.
Kargman, Stacia
Wong, Elizabeth
Chan, Chi Chung
Gordon, Robert
Xu, Li Jing
Riendeau, Denis
A series of novel 2,3-diaryl-2-cyclobuten-1-ones have been synthesized and have been evaluated with respect to their ability to inhibit the isozymes of cyclooxygenase, COX-1 and COX-2. 4,4-Dimethyl-2-phenyl-3-[4-(methylsulfonyl)phenyl]cyclobutenone 22 was found to be highly selective for inhibition of COX-2 and was orally active (ED50 = 2.4 mg/kg) in the rat paw edema model.
View MoreHANGZHOU GOPHER CHEM-TECH CO.,LTD
Contact:86-189-58111780
Address:Da Cheng Ming Zuo Plaza,Xiaoshan District
Nantong Kaixin Pharma Chemical Co.,Ltd.
Contact:86-513-85250786
Address:2-1103 Huachen Mansion, 111 Gongnong Road,Nantong, Jiangsu, China
NINGBO YINZHOU PRECISE COLOR CO.,LTD.
Contact:86-574-88139809 86-574-83033159
Address:Qiming Road,Yinzhou,Ningbo,China
Shanghai Hongbang Medical Technology CO.,. Ltd
Contact:13671516988 /18917636693
Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
Contact:86-571-86737118-8689
Address:No.69, 12 Street, HEDA, Hangzhou, Zhejiang, China
Doi:10.1016/S0960-894X(96)00561-6
(1996)Doi:10.1002/cctc.201601654
(2017)Doi:10.1002/anie.199701551
(1997)Doi:10.1016/S0040-4039(96)02196-X
(1997)Doi:10.1002/chem.19970031006
(1997)Doi:10.3797/scipharm.aut-04-02
(2004)
